NASDAQ · AHCO
Healthcare · Medical - Devices
$5.82
Down-$0.06 (-1.02%)
Updated Sep 16, 2026, 12:55 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
AHCO closed at $5.82 after 20 trading sessions, up 0.00% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $5.87 | $5.872 | $5.72 | $5.82 | 3.51M |
| Sep 14, 2026 | $6.13 | $6.24 | $5.855 | $5.88 | 3.72M |
| Sep 11, 2026 | $5.95 | $6.10 | $5.87 | $6.06 | 2.08M |
| Sep 10, 2026 | $5.75 | $5.91 | $5.71 | $5.85 | 3.23M |
| Sep 9, 2026 | $5.92 | $5.99 | $5.605 | $5.70 | 3.57M |
| Sep 8, 2026 | $6.48 | $6.52 | $6.105 | $6.19 | 2.89M |
| Sep 4, 2026 | $6.32 | $6.52 | $6.2425 | $6.49 | 2.61M |
| Sep 3, 2026 | $6.12 | $6.455 | $6.03 | $6.42 | 3.21M |
| Sep 2, 2026 | $5.60 | $6.14 | $5.56 | $6.04 | 3.67M |
| Sep 1, 2026 | $5.58 | $5.7041 | $5.455 | $5.51 | 2.38M |
| Aug 31, 2026 | $5.83 | $5.83 | $5.545 | $5.59 | 2.62M |
| Aug 28, 2026 | $5.80 | $5.885 | $5.77 | $5.79 | 1.76M |
| Aug 27, 2026 | $5.66 | $5.835 | $5.53 | $5.80 | 2.25M |
| Aug 26, 2026 | $5.47 | $5.685 | $5.39 | $5.67 | 2.26M |
| Aug 25, 2026 | $5.62 | $5.67 | $5.45 | $5.48 | 4.08M |
| Aug 24, 2026 | $5.63 | $5.66 | $5.555 | $5.63 | 1.74M |
| Aug 21, 2026 | $5.41 | $5.64 | $5.36 | $5.63 | 1.92M |
| Aug 20, 2026 | $5.61 | $5.695 | $5.32 | $5.39 | 2.69M |
| Aug 19, 2026 | $5.88 | $5.94 | $5.63 | $5.66 | 2.66M |
| Aug 18, 2026 | $5.80 | $5.95 | $5.72 | $5.82 | 3.16M |
The latest Smart Investors Daily articles mentioning AHCO.
AHCO research
Company profile and research snapshot.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | UBS | Buy | — |
| Aug 6, 2026 | RBC Capital | Outperform | — |
| Aug 5, 2026 | Truist Securities | Buy | — |
| Jul 21, 2026 | Jefferies | Buy | — |
| Jul 6, 2026 | Baird | Outperform | — |
No generated briefing is available yet.
Yahoo · Sep 11, 2026
PLYMOUTH MEETING, Pa., September 11, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences:
Yahoo · Sep 9, 2026
Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell 8.6% in the afternoon session after the company announced the appointment of Harriss T. Currie as Chief Financial Officer, taking over duties from Jason Clemens.
Yahoo · Sep 8, 2026
PLYMOUTH MEETING, Pa., September 08, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chief Financial Officer, effective September 9, 2026. Mr. Currie will assume CFO responsibilities from Jason Clemens, who will assist with the transition throu
Benzinga · Sep 8, 2026
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AHCO.
